Inhaled Corticosteroids
Inhaled Corticosteroids - Related Videos
01:25
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
0 Views •
2024
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation. ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
0 Views •
Cited by 51 •
2013
A whole-body nanoparticle aerosol inhalation exposure facility was constructed for nano-sized titanium dioxide (TiO2) inhalation toxicology studies. This system provides nano-TiO2 aerosol test atmospheres that have: 1) a steady mass concentration; 2) a homogenous composition free of contaminants; and 3) a stable particle size distribution during aerosol generation.
01:23
Inhaled Medications
0 Views •
2025
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:26
COPD: Management Using Bronchodilators and Corticosteroids
0 Views •
2024
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24
Pulmonary Ventilation: Inhalation
0 Views •
2025
Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system. Boyle's law becomes particularly pertinent when examining respiratory...
FAQs
After entering airway cells, the corticosteroid binds to a glucocorticoid receptor and changes gene transcription. This signaling reduces inflammatory mediators, limits immune-cell activity, and decreases airway swelling. The mechanism explains why benefits develop through regular control of airway inflammation rather than through an immediate change in symptoms.
Inhalation places the medicine near the airways, concentrating treatment at the respiratory target while limiting, but not eliminating, systemic exposure. This local-delivery principle distinguishes the route from approaches that distribute medicine more broadly through the body. It also explains why correct inhaler use remains important for achieving the intended airway effect.
Regular treatment decreases airway hyperresponsiveness, meaning the airways become less excessively reactive. This effect complements the reduction of inflammatory mediators, immune-cell activity, and swelling. Because these changes support prevention and control rather than immediate relief, the medicines are used consistently as maintenance therapy instead of being relied on for rapid symptom relief.
Clinical benefit depends strongly on adherence and inhaler technique. Inconsistent use reduces the regular anti-inflammatory exposure needed to control airway changes, while poor technique can interfere with delivering the medicine to the airways. These factors help explain why the pharmacologic potential of a treatment may not translate into equivalent symptom control for every patient.
The medicines are taken regularly as maintenance therapy to prevent and control respiratory symptoms, especially in asthma. Their role is ongoing management rather than rapid relief during sudden symptoms. A practical treatment approach therefore emphasizes consistent use and proper inhaler technique, because both influence whether the medicine reaches the airway target effectively.
Regular treatment can reduce exacerbations, improve lung function, and help control respiratory symptoms. These outcomes reflect the cumulative effect of suppressing airway inflammation and reducing hyperresponsiveness. In asthma pharmacology, the therapy is therefore evaluated by its contribution to prevention and long-term control, not solely by whether it produces an immediate sensation of relief.